Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Cash & Equivalents (2016 - 2025)

Scynexis (SCYX) has disclosed Cash & Equivalents for 13 consecutive years, with $56.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 250.76% year-over-year to $56.3 million, compared with a TTM value of $56.3 million through Dec 2025, up 250.76%, and an annual FY2025 reading of $56.3 million, up 250.76% over the prior year.
  • Cash & Equivalents was $56.3 million for Q4 2025 at Scynexis, up from $37.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $118.7 million in Q2 2022 and bottomed at $11.0 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $65.6 million, with a median of $57.1 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents surged 354.31% in 2021, then crashed 86.83% in 2025.
  • Year by year, Cash & Equivalents stood at $104.5 million in 2021, then plummeted by 56.15% to $45.8 million in 2022, then dropped by 25.68% to $34.0 million in 2023, then crashed by 52.86% to $16.1 million in 2024, then surged by 250.76% to $56.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for SCYX at $56.3 million in Q4 2025, $37.9 million in Q3 2025, and $11.0 million in Q2 2025.